Concurrent SF3B1 Mutation and BCR::ABL1 Demonstrating a Myelodysplastic Syndrome Phenotype: A Case Report

Documenti analoghi

• Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with BCR::ABL1 fusion
  di: Shohei Mizuno, et al.
  Pubblicazione: (2024)
• Unveiling the nephrotoxic profile of BCR‐ABL tyrosine kinase inhibitors: A real‐world experience in Africa
  di: Zekarias Seifu Ayalew, et al.
  Pubblicazione: (2024)
• From primary myelofibrosis to chronic myeloid leukemia, BCR::ABL1+ B‐Lymphoblastic leukemia, and back to primary myelofibrosis: An illustration of dynamic clonal evolution
  di: Devin Wang, et al.
  Pubblicazione: (2024)
• Flow Cytometry Analysis of Mesenchymal Stem Cells: A Predictive Biomarker for Leukemia Transformation in Myelodysplastic Syndrome
  di: Mireia Atance, et al.
  Pubblicazione: (2025)
• Development of Machine‐Assisted, Human‐Centred Bone Marrow Cell Classification: Feasibility Analysis in Patients With Myelodysplastic Syndromes
  di: Kiyoyuki Ogata, et al.
  Pubblicazione: (2025)